4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.51
-0.13 (-1.56%)
Mar 6, 2026, 3:40 PM EST - Market open
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $433.82 million as of March 6, 2026. Its market cap has increased by 98.40% in one year.
Market Cap
433.82M
Enterprise Value
76.97M
1-Year Change
98.40%
Ranking
Category
Stock Price
$8.51
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $433.82M, a decrease of -25.25%. That is a compound annual growth rate of -5.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 461.86M |
| Century Therapeutics | 459.90M |
| Immix Biopharma | 450.02M |
| Lineage Cell Therapeutics | 445.88M |
| REGENXBIO | 441.43M |
| Anavex Life Sciences | 441.12M |
| Altimmune | 438.94M |
| Assembly Biosciences | 437.50M |